Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
Avoro Capital Advisors LLC reported a 9.60% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Avoro Capital Advisors LLC reported a 9.60% stake in Arrowhead Pharmaceuticals, Inc., 12,028,552 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 12,028,552
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 9.60% | 12,028,552 |
| Behzad Aghazadeh | 9.60% | 12,028,552 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- Avoro Capital Advisors LLC
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2025
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Cohen Matthew Gregory · Jun 17, 2026